Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Journal of Alzheimer'S Disease : JAD|August 16, 2021
Inflammatory Chemokines Expression Variations and Their Receptors in APP/PS1 MiceAdrián Jorda, Martin Aldasoro, Constanza Aldasoro, et al.Plos One|November 28, 2022
Protective action of ultrasound-guided electrolysis technique on the muscle damage induced by notexin in ratsAdrian Jorda, Juan Campos-Campos, Constanza Aldasoro, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|February 1, 2020
The Role of Chemokines in Alzheimer's DiseaseAdrian Jorda, Juan Campos-Campos, Antonio Iradi, et al.International Journal of Molecular Sciences|September 9, 2023
Improvement of Vascular Insulin Sensitivity by RanolazineSol Guerra-Ojeda, Adrian Jorda, Constanza Aldasoro, et al.International Journal of Medical Sciences|March 29, 2020
Action of low doses of Aspirin in Inflammation and Oxidative Stress induced by aβ<sub>1-42</sub> on Astrocytes in primary cultureAdrian Jorda, Martin Aldasoro, Constanza Aldasoro, et al.International Journal of Medical Sciences|November 2, 2019
Function of Glia in Aging and the Brain DiseasesSoraya L Valles, Antonio Iradi, Martin Aldasoro, et al.International Journal of Molecular Sciences|October 14, 2022
Facilitation of Insulin Effects by Ranolazine in Astrocytes in Primary CultureAdrián Jordá, Martin Aldasoro, Ignacio Campo-Palacio, et al.International Journal of Medical Sciences|April 4, 2017
Neuronal Effects of Sugammadex in combination with Rocuronium or VecuroniumMartin Aldasoro, Adrian Jorda, Constanza Aldasoro, et al.Plos One|March 8, 2016
Effects of Ranolazine on Astrocytes and Neurons in Primary CultureMartin Aldasoro, Sol Guerra-Ojeda, Diana Aguirre-Rueda, et al.Neurosci|February 20, 2026
Inflammatory Mediators of Alzheimer's Disease Characterized in a Mouse Model (APP/PS1)Adrian Jorda, Kenia Alvarez-Gamez, Ignacio Campo-Palacio, et al.Pageof 2